Mrs. Jennifer Kathleen Garland, PLCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3191 Old Cape Rd, Jackson, MO 63755 Phone: 573-204-8901 Fax: 573-204-8902 |
Mrs. Melissa Lee Hale, MSW, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 10672 Us Highway 61, Jackson, MO 63755 Phone: 573-837-7144 Fax: 636-333-4510 |
Mrs. Rebecca Ellen Fielder, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2130 E Jackson Blvd, Jackson, MO 63755 Phone: 573-243-8408 Fax: 573-243-0445 |
Cindy Renee Aug, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 402 E Washington St, Jackson, MO 63755 Phone: 573-275-1508 |
Ms. Tamara L Goldrick, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 710 Broadridge Dr, Jackson, MO 63755 Phone: 888-365-6271 |
Nicole Leanne Horrell, PLCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3191 Old Cape Rd, Jackson, MO 63755 Phone: 573-204-8901 |
Samuel Duer, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 160 N Enterprise Ln, Jackson, MO 63755 Phone: 573-204-9200 Fax: 573-204-9203 |
Kayleen Marie Shaw, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4152 County Road 436, Jackson, MO 63755 Phone: 573-225-9226 |
News Archive
Eighty percent of large U.S. companies this year are offering chronic disease management programs for workers in an effort to reduce health care costs, up from 51% last year, according to a new survey by Hewitt Associates, the Houston Chronicle reports.
Efforts to avert the looming "fiscal cliff" have revived talk of raising Medicare's eligibility age. Some Republicans also suggest that spending to carry out the health law should be viewed as a source for savings. Meanwhile, an important meeting is scheduled for Wednesday.
In a study recently published on the bioRxiv* preprint server, researchers investigated the difference in replication efficiency or IFN sensitivity of the four VOCs.
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today positive results in its Phase 2 clinical trial, in which SGX942, a first-in-class Innate Defense Regulator (IDR), at a dose of 1.5 mg/kg, successfully reduced the median duration of severe oral mucositis by 50% in all patients and by 67% in patients receiving the most aggressive chemoradiation therapy (CRT) for treatment of their head and neck cancer.
With the ongoing challenges associated with large-scale testing for COVID-19-including test kit shortages, stringent testing criteria and the inherent limitations of current tracking systems on mildly symptomatic and asymptomatic populations, scientists are looking for alternate methods to boost testing in order to predict the spread of the disease.
› Verified 9 days ago